Share-based Payment Arrangement, Expense in USD of BICYCLE THERAPEUTICS PLC from 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Bicycle Therapeutics Plc quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2017 to Q3 2025.
  • Bicycle Therapeutics Plc Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $8.77M, a 4.68% decline year-over-year.
  • Bicycle Therapeutics Plc Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $38.1M, a 7.27% increase year-over-year.
  • Bicycle Therapeutics Plc annual Share-based Payment Arrangement, Expense for 2024 was $38.1M, a 17.3% increase from 2023.
  • Bicycle Therapeutics Plc annual Share-based Payment Arrangement, Expense for 2023 was $32.5M, a 21.3% increase from 2022.
  • Bicycle Therapeutics Plc annual Share-based Payment Arrangement, Expense for 2022 was $26.8M, a 122% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

BICYCLE THERAPEUTICS PLC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $38.1M $8.77M -$431K -4.68% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 $38.6M $9.44M +$171K +1.85% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025
Q1 2025 $38.4M $9.61M +$323K +3.48% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025
Q4 2024 $38.1M $10.3M +$2.52M +32.3% 01 Oct 2024 31 Dec 2024 10-K 25 Feb 2025
Q3 2024 $35.6M $9.2M +$1.77M +23.8% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025
Q2 2024 $33.8M $9.26M +$1.07M +13.1% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025
Q1 2024 $32.7M $9.28M +$240K +2.65% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025
Q4 2023 $32.5M $7.81M +$2.27M +41% 01 Oct 2023 31 Dec 2023 10-K 25 Feb 2025
Q3 2023 $30.2M $7.43M +$2.06M +38.4% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024
Q2 2023 $28.1M $8.19M +$2.52M +44.4% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024
Q1 2023 $25.6M $9.04M -$1.16M -11.3% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024
Q4 2022 $26.8M $5.54M +$2.54M +84.7% 01 Oct 2022 31 Dec 2022 10-K 25 Feb 2025
Q3 2022 $24.2M $5.37M +$2.68M +99.7% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023
Q2 2022 $21.6M $5.67M +$3.1M +120% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023
Q1 2022 $18.5M $10.2M +$6.38M +167% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023
Q4 2021 $12.1M $3M +$1.44M +91.8% 01 Oct 2021 31 Dec 2021 10-K 20 Feb 2024
Q3 2021 $10.6M $2.69M +$1.18M +78% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022
Q2 2021 $9.47M $2.58M +$1.26M +95.2% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022
Q1 2021 $8.21M $3.82M +$1.7M +80.2% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022
Q4 2020 $6.51M $1.56M +$481K +44.4% 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2023
Q3 2020 $6.03M $1.51M +$691K +84.4% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021
Q2 2020 $5.34M $1.32M +$414K +45.7% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021
Q1 2020 $4.93M $2.12M +$1.85M +668% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q4 2019 $3.08M $1.08M 01 Oct 2019 31 Dec 2019 10-K 01 Mar 2022
Q3 2019 $819K +$589K +256% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020
Q2 2019 $905K +$570K +170% 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2020
Q1 2019 $276K 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020
Q3 2018 $230K 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019
Q2 2018 $335K 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019

BICYCLE THERAPEUTICS PLC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $38.1M +$5.6M +17.3% 01 Jan 2024 31 Dec 2024 10-K 25 Feb 2025
2023 $32.5M +$5.7M +21.3% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2025
2022 $26.8M +$14.7M +122% 01 Jan 2022 31 Dec 2022 10-K 25 Feb 2025
2021 $12.1M +$5.57M +85.5% 01 Jan 2021 31 Dec 2021 10-K 20 Feb 2024
2020 $6.51M +$3.43M +111% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023
2019 $3.08M +$2.06M +201% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022
2018 $1.02M +$508K +98.6% 01 Jan 2018 31 Dec 2018 10-K 11 Mar 2021
2017 $515K 01 Jan 2017 31 Dec 2017 10-K 10 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.